Project Grant HT94252410074
Award Date
2/1/24
Completion Date
1/31/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
The Department of the Army Medical Command awarded a $782,955.27 Project Grant to Vanderbilt University Medical Center on September 15, 2022, with a completion date of September 14, 2025. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to modulate lung and bone microenvironments to treat breast cancer metastases. The program aims to transform military and public health through innovative biomedical research solutions for battlefield...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $2,264,623 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective May 1, 2025 through April 30, 2029, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. Specifically, the grant will fund research on toxicant-mediated pulmonary hypertension in Southwest Asia...
The Department of the Army Medical Command awarded Vanderbilt University a $1.6 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research into Modulation of Lung and Bone Microenvironments to Treat Breast Metastases. The three-year award beginning September 15, 2022 will fund investigation into medical solutions for breast cancer that has metastasized to the lungs and bones. As part of the Military Medical Research and Development...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
This federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $2,399,874.00 to Vanderbilt University Medical Center (VUMC) to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. The 4-year research project, titled "Decoding the Inflammatory Spark and Fire: Unraveling the Molecular Basis of Post-Injury Syndrome and...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center a $1.4 million cooperative agreement from September 15, 2021 to September 14, 2024 under the Military Medical Research and Development program (CFDA 12.420). The award will support Vanderbilt's Kidney Cancer Clinical Trials Consortium to conduct clinical trials investigating medical solutions for kidney cancer through the Military Medical Research and Development program's goals of transforming military and...
Vanderbilt University Medical Center was awarded a $1,727,296 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from February 15, 2022 to February 14, 2025 to assess the role of intracellular parathyroid hormone-related protein signaling in mechanisms of tumor dormancy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The Department of the Army Medical Command has awarded a $2,192,538 Military Medical Research and Development (CFDA 12.420) Project Grant to Vanderbilt University Medical Center (VUMC) to support research on toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The 4-year grant, which runs from April 1, 2025 to April 30, 2029, will fund advanced biomedical research aimed at transforming healthcare for military service members and the broader public. VUMC, a prominent academic...
This $1,432,794 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project at Vanderbilt University Medical Center (VUMC) titled "Gene Expression Analysis of Circulating Tumor Cells: A Next-Generation Biomarker to Predict Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma". The 4-year project, with a start date of September 15, 2024 and end date of September...